Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Prenatal High Estradiol Exposure Induces Sex-Specific and Dietarily Reversible Insulin Resistance Through Decreased Hypothalamic INSR.

Endocrinology | 2018

An adverse intrauterine environment may induce adult disease in offspring, but the mechanisms are not well understood. It is reported that fresh embryo transfer (ET) in assisted reproductive technology leads to high maternal estradiol (E2), and prenatal high E2 exposure increases the risk of organ disorders in later life. We found that male newborns and children of fresh ET showed elevated fasting insulin and homeostasis model of assessment for insulin resistance index (HOMA-IR) scores. Male mice with high prenatal estradiol exposure (HE) grew heavier than control mice and developed insulin resistance; they also showed increased food intake, with increased orexigenic hypothalamic neuropeptide Y (NPY) expression. The hypothalamic insulin receptor (INSR) was decreased in male HE mice, associated with elevated promoter methylation. Chronic food restriction (FR) in HE mice reversed insulin resistance and rescued hypothalamic INSR expression by correcting the elevated Insr promoter methylation. Our findings suggest that prenatal exposure to high E2 may induce sex-specific metabolic disorders in later life through epigenetic programming of hypothalamic Insr promoter, and dietary intervention may reverse insulin resistance by remodeling its methylation pattern.

Pubmed ID: 29155986 RIS Download

Additional research tools detected in this publication

None found

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Insulin Receptor antibody [EPR5510(2)] (antibody)

RRID:AB_11155955

This monoclonal targets Insulin Receptor antibody [EPR5510(2)]

View all literature mentions

Anti-rabbit IgG, HRP-linked Antibody (antibody)

RRID:AB_2099233

This polyclonal secondary targets IgG

View all literature mentions

Estrogen Receptor beta antibody [14C8] (antibody)

RRID:AB_303379

This monoclonal targets Estrogen Receptor beta antibody [14C8]

View all literature mentions

β-Actin (8H10D10) Mouse mAb (antibody)

RRID:AB_2242334

This monoclonal targets beta-actin

View all literature mentions

POMC (D3R1U) Rabbit mAb (antibody)

RRID:AB_2716565

This monoclonal targets Pro-Opio-Melano-Cortin (POMC) protein

View all literature mentions

Insulin Receptor antibody [EPR5510(2)] (antibody)

RRID:AB_11155955

This monoclonal targets Insulin Receptor antibody [EPR5510(2)]

View all literature mentions

Estrogen Receptor beta antibody [14C8] (antibody)

RRID:AB_303379

This monoclonal targets Estrogen Receptor beta antibody [14C8]

View all literature mentions

β-Actin (8H10D10) Mouse mAb (antibody)

RRID:AB_2242334

This monoclonal targets beta-actin

View all literature mentions

Insulin Receptor antibody [EPR5510(2)] (antibody)

RRID:AB_11155955

This monoclonal targets Insulin Receptor antibody [EPR5510(2)]

View all literature mentions

Anti-rabbit IgG, HRP-linked Antibody (antibody)

RRID:AB_2099233

This polyclonal secondary targets IgG

View all literature mentions

POMC (D3R1U) Rabbit mAb (antibody)

RRID:AB_2716565

This monoclonal targets Pro-Opio-Melano-Cortin (POMC) protein

View all literature mentions

Insulin Receptor antibody [EPR5510(2)] (antibody)

RRID:AB_11155955

This monoclonal targets Insulin Receptor antibody [EPR5510(2)]

View all literature mentions